Metagenomi, Inc. Common Stock
MGX
$1.16-0.85%
End of day · as of Sep 9, 2026, 2:00 AM ET
Mkt cap
$44.42M
EV/Sales
0.11
P/E ratio
N/A
FY2025 Revenue
$25.21M
EPS (TTM)
$-2.49
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-348.54%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Use this MGX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MGX income, balance, and cash tables.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company in the Healthcare sector.
Latest cached Metagenomi, Inc. Common Stock (MGX) revenue for Dec 31, 2025 was $25.2M. Net income was -$87.9M. Statements: https://lician.com/financials/mgx
Metagenomi, Inc. Common Stock (MGX) market capitalization is $44.4M on the latest cached snapshot.
Metagenomi, Inc. Common Stock (MGX) cached previous close $1.17; day range $1.13 – $1.18; volume 293,698. Session quote: https://lician.com/quote/mgx
Metagenomi, Inc. Common Stock (MGX) latest cached earnings event is "MGX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MGX filing is 8-K · Sep 22, 2026. Filings: https://lician.com/sec/mgx